Phase I Trial of Chemoimmunotherapy and Hypofractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Gemcitabine (Primary) ; Tadalafil (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- Acronyms CRIT
- 03 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
- 03 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 28 Mar 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017 as per ClinicalTrials.gov record.